Simulations Plus' (SLP) Outperform Rating Reiterated at William Blair

Simulations Plus (NASDAQ:SLP - Get Free Report)'s stock had its "outperform" rating reiterated by investment analysts at William Blair in a note issued to investors on Wednesday,RTT News reports.

Several other equities analysts also recently weighed in on SLP. BTIG Research decreased their price target on shares of Simulations Plus from $60.00 to $50.00 and set a "buy" rating on the stock in a research note on Thursday, October 24th. Stephens began coverage on shares of Simulations Plus in a research note on Friday, November 15th. They issued an "overweight" rating and a $39.00 target price on the stock. Finally, StockNews.com cut Simulations Plus from a "hold" rating to a "sell" rating in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $49.00.

Simulations Plus Trading Down 7.2 %

NASDAQ:SLP traded down $2.18 during trading hours on Wednesday, reaching $28.21. 1,535,907 shares of the company were exchanged, compared to its average volume of 563,121. The firm has a market cap of $566.60 million, a PE ratio of 57.57 and a beta of 0.80. Simulations Plus has a twelve month low of $24.00 and a twelve month high of $51.22. The stock's 50-day moving average is $29.80 and its 200-day moving average is $34.04.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The firm had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. During the same quarter in the prior year, the firm earned $0.18 EPS. The company's revenue for the quarter was up 19.9% on a year-over-year basis. As a group, research analysts anticipate that Simulations Plus will post 1.1 EPS for the current year.

Insider Buying and Selling

In other news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total value of $635,200.00. Following the sale, the director now directly owns 3,442,584 shares of the company's stock, valued at approximately $109,336,467.84. The trade was a 0.58 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 19.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Simulations Plus

Several hedge funds have recently bought and sold shares of SLP. JPMorgan Chase & Co. lifted its position in shares of Simulations Plus by 106.0% during the third quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company's stock worth $1,517,000 after purchasing an additional 24,371 shares in the last quarter. Principal Financial Group Inc. boosted its position in Simulations Plus by 2.6% in the 3rd quarter. Principal Financial Group Inc. now owns 87,273 shares of the technology company's stock valued at $2,794,000 after buying an additional 2,226 shares during the period. Franklin Resources Inc. grew its stake in shares of Simulations Plus by 7.6% in the third quarter. Franklin Resources Inc. now owns 10,797 shares of the technology company's stock worth $342,000 after acquiring an additional 766 shares in the last quarter. Barclays PLC increased its position in shares of Simulations Plus by 390.6% during the third quarter. Barclays PLC now owns 28,473 shares of the technology company's stock worth $911,000 after acquiring an additional 22,669 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in Simulations Plus by 4.4% in the third quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company's stock valued at $14,367,000 after purchasing an additional 18,924 shares during the period. Institutional investors and hedge funds own 78.08% of the company's stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.